MedBioSphere
Articles Videos The Web  
    

The New England Journal of Medicine

Selected Abstract

The New England Journal of Medicine Publishes the STEEPLE Study Which Demonstrated Superior Safety Profile of LOVENOX(R)(Enoxaparin Sodium Injection) Vs. Unfractionated Heparin (UFH) in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention (PCI).
- International Study Reveals Benefits of Treatment with Intravenous Enoxaparin, Including Achievement of Target Anticoagulation Levels and the Reduction of Major Bleeding When Compared to IV Unfractionated Heparin (UFH) - BRIDGEWATER, N.J., Sept. 7 /PRNewswire-FirstCall/ -- The New England Journal ...
September 7, 2006; PR Newswire

Read the full article with a free-trial membership at HighBeam Research



Related Articles

1. The New England Journal of Medicine Selects Mark Logic to Help Deliver New Ways to Search Case Records; Leading Medical Publisher Deploys MarkLogic Server to Launch ``Search Case Records'' Application.
2. Healthgate Data Corp.'s activePress(TM) Service Selected by The New England Journal of Medicine.
3. Merck & Co., Inc. Response to an Editorial Posted on the New England Journal of Medicine Web Site.(Editorial)
4. McGraw-Hill Education States Harrison's Online and The New England Journal of Medicine Form On-Line Collaboration to Expand Access.
5. The New England Journal of Medicine Publishes Results of Pivotal Trials Demonstrating Efficacy and Safety of FUZEON(TM), World's First FDA-Approved HIV Fusion Inhibitor; Journal Also Highlights Urgent Need for New Classes of HIV Therapies.
6. Interview: Robert Jay Lifton discusses his article, Doctors and Torture, in The New England Journal of Medicine
7. News and Views: The New England Journal of Medicine Produces Flat-Out Proof of Racism in Medicare-Funded Medicine
8. Genomic Medicine. Articles from the New England Journal of Medicine
9. Research Published in the New England Journal of Medicine Shows Benefits Of Chronic Aerosolized Antibiotic Therapy.
10. Feb. 23 'The New England Journal of Medicine' Reviews the GAIT Study: Glucosamine, Chondroitin Sulfate and the Two in Combination for Painful Knee Osteoarthritis.